User Tools

Site Tools


covid-19:treatments:drug_therapies

Drug Therapies Researched or Applied to Treat COVID-19

From early on during the COVID-19 pandemic, many potential drug therapies became and remain controversial. The various medications in this article may include both effective and ineffective treatments of the SARS-CoV-2 virus and the resulting COVID-19 disease state. The primary purpose is to categorize and summarize those treatments here.

How to Procure SARS-CoV-2/COVID-19 Prophylaxis and Treatments

Research Summaries

Hundreds of studies on dozens of drugs used during the COVID-19 pandemic are documented and summaried at www.c19study.com.

Antiseptic Mouth/Nose Wash

Antidepressants

While antidepressants may not seem like the most important class of repurposed drugs, COVID-19 is a unique disease, and it may not always be clear what biochemical influences might help some of those affected fight off the disease.

Antivirals

An antiviral agent is any agent that works as an antiviral, and may or may not otherwise be ordinarily recognized as a drug or have other medical uses.

See also zinc ionophores

Anti-Androgen Therapy

Blood Thinners/Anticoagulants

Since clotting is among the most damaging symptoms of COVID-19, numerous anticoagulants have been used by some doctors.

Fusion Inhibitor Peptides

Enfuvirtide

An in silico study showed that enfuvirtide can act as a potent SARS-CoV-2 fusion inhibitor.1)

Immune Modulators

Oxygen

Ventilators

Steroids

Corticosteroids

Other Mechanisms of Action

Public Health Measures

Vaccines

Many COVID-19 vaccines have been deployed with others in the development pipeline.

Vitamins, Minerals, and Nutraceuticals

Many vitamins, minerals, and nutraceutical supplements have been proposed, tested, or used in the treatment of SARS-CoV-2 and COVID-19.

Multidrug Treatment Protocols

Many medical doctors have shared the results of multidrug treatment protocols that they have used with patients in their practice.

Protocol Name # of patients treated # of patients hospitalized # of patients died Case Fatality Rate
Dr. Syed Haider IVM + FLV2) 4,000+ 5 0 0
Zelenko High Risk Patient Protocol 3) 141 4 1 0.7%
Tyson Farid mild 7,000 2 0 0
Tyson Farid moderate4) 413 7 3 0.7%
Italy Protocol 66,000 ? 4 0.00606%
Chetty 8th Day Therapy 5) 6) 4,000
Demello 7) 10,000+ ?? ?? ??

Dr. Peter McCullough has also developed early outpatient treatment protocols, publishing his findings at the end of 2020 and beginning of 2021: https://pubmed.ncbi.nlm.nih.gov/33387997/ https://pubmed.ncbi.nlm.nih.gov/32771461/

covid-19/treatments/drug_therapies.txt · Last modified: 2022/04/27 15:13 by mathew